Detalhe da pesquisa
1.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Mol Cancer
; 22(1): 133, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573301
2.
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Haematologica
; 105(2): 435-447, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123029
3.
Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.
Carcinogenesis
; 35(10): 2331-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25031272
4.
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies.
Cancer Cell
; 41(12): 2136-2153.e13, 2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37995682
5.
HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.
Oncogene
; 41(44): 4841-4854, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171271
6.
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
Oncogene
; 40(6): 1091-1105, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33323974
7.
Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia.
Leukemia
; 34(5): 1266-1277, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31780813
8.
STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Cancers (Basel)
; 12(4)2020 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326377
9.
Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia.
Front Oncol
; 9: 850, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31552175
10.
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease.
Cancer Cell
; 35(1): 125-139.e9, 2019 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30645971
11.
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
Leukemia
; 32(8): 1713-1726, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29728695
12.
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.
Vet Comp Oncol
; 16(1): 55-68, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397975
13.
Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation.
Mol Cancer Res
; 16(1): 135-146, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28974560
14.
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.
Expert Opin Ther Targets
; 22(1): 45-57, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29148847
15.
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target.
Leukemia
; 37(12): 2507-2511, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919605
16.
Pharmacologic inhibition of STAT5 in acute myeloid leukemia.
Leukemia
; 32(5): 1135-1146, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472718
17.
Preloading with L-BPA, L-tyrosine and L-DOPA enhances the uptake of [18F]FBPA in human and mouse tumour cell lines.
Appl Radiat Isot
; 118: 67-72, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619946